Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Genomenon, a US-based genome sequencing analysis software spinout of University of Michigan, secured $5.3m in a funding round yesterday backed by Michigan Rise and Red Cedar Ventures, a state-backed seed fund managed by and an early-stage venture arm of Michigan State University Foundation. The round also attracted insurer Atain Specialty Insurance, BroadOak Capital Partners, Green Park & Golf Ventures, Invest Detroit Ventures, IrishAngels, Michigan Angel Fund and Invest Michigan. Genomenon previously secured an undisclosed sum from Michigan Rise in September 2020. Metagen Therapeutics, a Japan-based microbiome drug developer spun out of Tokyo Institute of Technology, has raised ¥90m (825,000) from Keio Innovation Initiative, a vehicle for Keio University, and biotechnology-focused venture capital firm Fast Track Initiative. The spinout was incubated by Tech Planter, a startup incubator and accelerator scheme operated by research firm Leave a Nest, in 2015 and received an undisclosed amount of funding from the latter two years after. – Additional reporting by Liwen-Edison Fu

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).